Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: E_K_S	11/5/2008 4:18:50 PM
	Read Replies (1) of 78746

Started a small position in Amylin Pharmaceuticals Inc. (AMLN)a biopharmaceutical company that is in the discovery, development, and commercialization of medicines for diabetes and obesity. The stock is selling at a seven year low due to a setback in one of their phase III trials for their diabetes drug exenatide LAR. Exenatide LAR, which would be taken once-weekly, is poised to be the next version of Byetta (containing a component lizard spit to help treat type 2 diabetes) which is taken twice daily. The FDA notice would delay the release of Exenatide but not terminate the drug. For a BioTech company, the stock is really cheap. The company has enough cash to finish the trial and obtain the FDA approval. finance.yahoo.com It seems like the risk/reward is good especially once an approval is obtained, LLY will be their partner to market the drug. ============================================================= Buys today included MRK, FR AMLN DD finance.yahoo.com Some tax loss sells include finance.yahoo.com These sells were some higher priced shares that I may revisit in 31 days. I have been buying more EI DuPont de Nemours & Co. (DD) at current levels as I like their exposure in the solar business. I gave up on AMAT and moved the proceeds to DD. It pays a higher dividend and can be considered an equivalent solar play. EKS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next